Diabetes and endocrinology symposium: genes, environment and emerging therapies

This symposium provided an update in various areas within the fields of diabetes and endocrinology. Topics included the effects of diet and exercise on the metabolic syndrome and cardiovascular disease; programmes to decrease the incidence of diabetes; updates in the genetics of phaeochromocytoma, obesity and type 2 diabetes; the use of pegvisomant in acromegaly and incretin-based therapies in type 2 diabetes; and the relative strengths and weaknesses of bisphosphonates and HRT as treatment for post-menopausal osteoporosis.